Medical Design and Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • Subscribe to Print Magazine
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech

CMC Biologics Announces Appointment of New CEO

May 2, 2011 By Bio-Medicine.Org

COPENHAGEN, Denmark and SEATTLE, May 2, 2011 /PRNewswire/ — CMC
Biologics, a leading biopharmaceutical Contract Manufacturing
Organization, with operations in Copenhagen, Denmark and Seattle,
Washington USA, announced today that it has hired Claes Glassell to
serve at its Chief Executive Officer. CMC Biologics, a company with
370 employees, is committed to delivering  world class, fully
integrated, biopharmaceutical process development and manufacturing
services.

(Logo:  http://photos.prnewswire.com/prnh/20110502/SF93356LOGO)

Claes Glassell brings more than 30 years of industry experience
to CMC, most recently as CEO of Cerus Corporation and prior to that
as President of Cambrex Corp.

“We are thrilled that Claes has joined the CMC executive team,”
said David Kauffmann, Chairman of the Board, CMC Biologics, and
Managing Director of European Equity Partners. “Claes has been on
CMC’s board of directors for more than 5 years, and has during that
time exhibited a broad range of experience and insight of our
industry. Claes’ strong leadership qualities and seasoned business
understanding makes him the ideal leader to take CMC Biologics to
the next level as a leader in our fast moving industry.”

“Joining the CMC Executive team at this important time in the
Company’s lifecycle is a great privilege,” said Claes Glassell.
“The Company has, despite a very challenging environment in recent
years, been successful in continuing to realize strong growth.
Today, CMC has a very solid order book demonstrating the strength
of the Company’s world class service offering, management and
science team. CMC is positioned to be a highly successful
company.”

Claes Glassell joined the CMC board of directors in 2005. Claes
left the position as President & CEO of Cerus Corporation, Inc.
to take on the position as CEO of CMC Biologics. He is the former
President of Cambrex Cor

‘/>”/>

SOURCE

Related Articles Read More >

TE Connectivity opens global medical device prototyping center in Ireland
Prix Galien USA 2022 nominees
The 24 best medical device innovations of 2022
A portrait of Ellen Roche, MIT School of Engineering associate professor
New implant design prevents scar tissue without drugs, MIT says
UMN artificial blood vessel clinical trial
Minnesota researchers awarded $3.7M grant for artificial, bioengineered blood vessel clinical trial

DeviceTalks Weekly.

August 12, 2022
DTW – Medtronic’s Mauri brings years of patient care to top clinical, regulatory, scientific post
See More >

MDO Digital Edition

Digital Edition

Subscribe to Medical Design & Outsourcing. Bookmark, share and interact with the leading medical design engineering magazine today.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
DeviceTalks

DeviceTalks is a conversation among medical technology leaders. It's events, podcasts, webinars and one-on-one exchanges of ideas & insights.

DeviceTalks

New MedTech Resource

Medical Tubing

Enewsletter Subscriptions

Enewsletter Subscriptions

MassDevice

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website
MDO ad
Medical Design and Outsourcing
  • MassDevice
  • DeviceTalks
  • MedTech100 Index
  • Medical Tubing + Extrusion
  • Medical Design Sourcing
  • Drug Delivery Business News
  • Drug Discovery & Development
  • Pharmaceutical Processing World
  • R&D World
  • About Us/Contact
  • Advertise With Us
  • Subscribe to Print Magazine
  • Subscribe to E-newsletter
  • Attend our Monthly Webinars
  • Listen to our Weekly Podcasts
  • Join our DeviceTalks Tuesdays Discussion

Copyright © 2022 WTWH Media, LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media LLC. Site Map | Privacy Policy | RSS

Search Medical Design & Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • Subscribe to Print Magazine
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech